Summary:
- The article outlines the FDA's regulatory framework for Software as a Medical Device (SaMD), specifically focusing on the integration of Artificial Intelligence and Machine Learning (AI/ML) in healthcare tools.
- It details the lifecycle approach for AI-enabled devices, emphasizing the importance of transparency, algorithmic performance, and continuous monitoring to ensure patient safety and clinical effectiveness.